Google
 

Archive for the ‘Bones / Orthopaedics’ Category

Office Initiative Reduces Headaches And Neck And Shoulder Pain By More Than 40 Per Cent

Friday, May 16th, 2008

Office staff who took part in an eight-month workplace initiative reported that headaches and neck and shoulder pain fell by more than 40 per cent and their use of painkillers halved, according to research published in the May issue of Cephalalgia. They also reported that pain levels were less severe ...

Orthopaedic Hospital Offers Low Cost Bone Density Screenings In Observance Of National Women’s Health Week And May Osteoporosis Prevention Month

Friday, May 16th, 2008

For most people, the month of May is synonymous with the time tested tradition of spring cleaning and organizing. As many people set aside time for spring activities, May also signifies National Women's Health Week (May 11 - 17) and Osteoporosis Prevention Month - two significant occasions that Orthopaedic Hospital ...

Docs Issue Guideline on Screening for Osteoporosis in Men

Thursday, May 15th, 2008

May 7 -- A new clinical guideline on screening for osteoporosis in men has been developed by the American College of Physicians , which notes that osteoporosis rates among men are expected to increase 50 percent over the next 15 years.Osteoporosis-related fractures in men result in substantial disease, death ...

Epilepsy Drug Linked to Bone Loss

Tuesday, April 29th, 2008

April 28 -- The epilepsy drug Dilantin may put young women who take it for a year or more at higher risk for osteoporosis, researchers report.The bone loss described in a paper in the April 29 issue of Neurology was actually eight times higher than that experienced by premenopausal ...

New Dyneema Purity(R) Ug Grade Delivers Enhanced Performance To Support Long-Term Strength Of Implants

Saturday, April 12th, 2008

At the World Biomaterials Congress, May 28 till June 1, DSM will introduce an important expansion of its high-performance Dyneema Purity® polyethylene fiber portfolio that is targeted to provide increased lifetime and 25 percent greater strength than the original product. This new material, Dyneema Purity® UG, was developed specifically to ...

NewYork-Presbyterian/Weill Cornell Creates Program Dedicated To Treating Facial And Skull Malformations In Children

Friday, April 11th, 2008

A new craniofacial surgery program has opened at NewYork- Presbyterian Hospital/Weill Cornell Medical Center. Made possible by a generous gift to the Hospital from NewYork-Presbyterian trustee David H. Komansky and his wife Phyllis Komansky, the program will offer comprehensive care, including corrective surgery, for deformities of the skull, face and ...

Prevention Of Osteoporosis Might Lie In The Letter “D”

Friday, April 11th, 2008

Sixty-year-old Darlene Yates has had two hip replacements, a knee replacement and this past year shattered her left femur while she was walking in her neighborhood. Her diagnosis seemed obvious -- osteoporosis. But it turns out she had bone weakness caused by a vitamin D deficiency."I thought with my age ...

‘Reading’ Bones Can Reveal How Fast You’ll Age But Intervention Programs Can Slow The Aging Process

Thursday, April 10th, 2008

Perhaps the aging process can't be stopped. But it can be predicted, and new research from Tel Aviv University indicates that people may live longer and lead healthier lives as a result.Researchers have developed a new biological marker that represents the age of a body's bones. It reveals that the ...

Drug Found Safe And Effective In Patients With Chronic Kidney Disease

Thursday, April 10th, 2008

The osteoporosis drug raloxifene increases bone mineral density and reduces the risk of vertebral fractures among postmenopausal women with mild to moderate chronic kidney disease (CKD), according to a study appearing in the July 2008 issue of the Journal of the American Society Nephrology. The findings indicate that raloxifene is ...

Landmark Study Aims To Improve Osteoporosis Care Standards Worldwide - Multi-national Study Will Follow 60,000 Women For 5 Years

Thursday, April 10th, 2008

Nearly 60,000 women aged 55 years and older have enrolled in a landmark, multi-national study that will focus on the management of osteoporosis across the globe. Launch of the Global Longitudinal Registry of Osteoporosis in Women (GLOW) was announced today at ECCEO 8 (Eighth European Congress on Clinical ...

New Research Adds To Growing Body Of Knowledge Of Genetics Of Height

Wednesday, April 9th, 2008

Scientists are beginning to develop a clearer picture of what makes some people stand head and shoulders above the rest. A team of researchers who last year identified the first common version of a gene influencing height has now identified a further twenty regions of the genome which together can ...

Anesiva Announces Pivotal Phase 3 Clinical Trial Of Adlea(TM) For Reducing Post-Surgical Pain Following Total Knee Replacement

Wednesday, April 9th, 2008

Anesiva, Inc. (Nasdaq: ANSV) announced that a pivotal Phase 3 clinical trial evaluating Adlea(TM), its long-acting, non-opioid analgesic drug candidate, in patients following total knee replacement surgery, is underway. In September 2007, Anesiva initiated a multicenter, randomized, double-blind, placebo-controlled Phase 2 trial to evaluate the safety and ...

Award Winning Study Says Back Pain May Be In Your Genes

Wednesday, April 9th, 2008

What do you learn by looking at the spines of hundreds of Finnish twins? If you are the international team of researchers behind the Twin Spine Study, you find compelling proof that back pain problems may be more a matter of genetics than physical strain. The findings ...

Biological Clock Linking Tooth Growth To Other Metabolic Processes Discovered By NYU Dental Professor

Monday, April 7th, 2008

This clock, or biological rhythm, controls many metabolic functions and is based on the circadian rhythm, which is a roughly 24-hour cycle that is important in determining sleeping and feeding patterns, cell regeneration, and other biological processes in mammals.The newly discovered rhythm, like the circadian rhythm, originates in the hypothalamus, ...

FORSTEO(R) Receives Approval From The European Commission For The Treatment Of Glucocorticoid Induced Osteoporosis

Saturday, April 5th, 2008

Eli Lilly and Company (NYSE: LLY) announced that the European Commission has approved a new indication for FORSTEO(R) (teriparatide [rDNA origin] injection) for the treatment of osteoporosis associated with sustained, systemic glucocorticoid therapy in women and men at increased risk for fracture.This approval follows the initial positive opinion issued ...